As a model of nonobese T2DM, the STZ + NAA system has distinct advantages for diabetes research: it maintains stable moderate hyperglycemia without requiring exogenous insulin for animal survival, retains partial glucose-stimulated insulin secretion capacity, and responds to sulfonylureas. Here, INS is linked to type 2 diabetes mellitus.